Stay updated on Eplontersen in ATTR CM: Clinical Trial
Sign up to get notified when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.

Latest updates to the Eplontersen in ATTR CM: Clinical Trial page
- Check3 days agoChange DetectedAdded a government funding lapse notice at the top of the page explaining possible data delays and directing users to opm.gov. Updated the site release version to Revision: v3.4.1 (replacing v3.4.0).SummaryDifference0.2%

- Check10 days agoChange DetectedAdded a Show glossary option and new labels: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check17 days agoChange DetectedRevision: v3.3.4 is displayed, replacing v3.3.3. This update does not modify study information or how users interact with the page.SummaryDifference0.0%

- Check46 days agoChange DetectedExpanded global study locations with many new sites across the United States, Canada, Europe, Australia, and other regions; several existing locations have been removed.SummaryDifference3%

- Check67 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision history updated: added Revision: v3.3.1 and removed Revision: v3.2.0; this change does not affect the study details or core page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Eplontersen in ATTR CM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.